Long-term survival of fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a US population-based study
- PMID: 24440939
- PMCID: PMC4822547
- DOI: 10.1097/MCG.0000000000000070
Long-term survival of fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a US population-based study
Figures
Comment on
-
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.J Clin Gastroenterol. 2014 Mar;48(3):279-89. doi: 10.1097/MCG.0b013e3182a8a793. J Clin Gastroenterol. 2014. PMID: 24045276
References
-
- Weinmann A, Koch S, Niederle IM, et al. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. J Clin Gastroenterol. 2013 Epub ahead of print. - PubMed
-
- Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd. Geneva: World Health Organization; 2010.
-
- El Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39:798–803. - PubMed
-
- Kakar S, Burgart LJ, Batts KP, et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18:1417–1423. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
